ArticleDiabetes, obesity & metabolism2026
Circulating Rhythmic Metabolites and Causal Risk of Type 2 Diabetes in Adults in the Canadian Longitudinal Study on Aging.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
aimsCircadian regulation of metabolism is an important factor in metabolic health, yet the role of rhythmic metabolites in Type 2 diabetes development remains poorly understood. This study investigated associations between circulating rhythmic metabolites and incident Type 2 diabetes risk and evaluated causal relationships using two-sample Mendelian randomisation. MATERIALS AND
methodsWe analysed longitudinal data from 9992 community-dwelling adults aged 45-85 years (49.1% male) in the Canadian Longitudinal Study on Aging with baseline (2012-2015) serum metabolomics data. Untargeted metabolomics profiling was conducted using ultrahigh-performance liquid chromatography-tandem mass spectrometry. Incident Type 2 diabetes at 3-year follow-up was assessed based on diabetes medication use and HbA1c level. Associations between rhythmic metabolites and diabetes risk were evaluated using multivariable binomial regression. Pathway and network analyses were conducted to explore underlying biological mechanisms. Causality was assessed using two-sample Mendelian randomisation for rhythmic metabolites significantly associated with diabetes risk.
resultsAltogether, 20 rhythmic metabolites were associated with Type 2 diabetes risk, including a subset overlapping with genetic predisposition to chronotype, suggesting potential circadian regulation. Key pathways included leucine, isoleucine and valine biosynthesis and degradation, and glycine, serine and threonine metabolism. Mendelian randomisation analyses revealed causal associations between higher levels of mannose, valine, isoleucine, threonine and sphingomyelin (d18:0/18:0, d19:0/17:0) and higher Type 2 diabetes risk, whereas creatine, glycine, 1-linoleoyl-GPC (18:2), 1-palmitoyl-2-oleoyl-GPE, 1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) and 1-stearoyl-2-oleoyl-GPE (18:0/18:1) were protective.
conclusionsDisruptions in rhythmic metabolites are implicated in Type 2 diabetes pathophysiology through specific metabolic pathways, highlighting the potential for biomarkers to support circadian-based prevention strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.